Correlation Between Aslan Pharmaceuticals and Agios Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aslan Pharmaceuticals and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aslan Pharmaceuticals and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aslan Pharmaceuticals and Agios Pharm, you can compare the effects of market volatilities on Aslan Pharmaceuticals and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aslan Pharmaceuticals with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aslan Pharmaceuticals and Agios Pharm.

Diversification Opportunities for Aslan Pharmaceuticals and Agios Pharm

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aslan and Agios is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Aslan Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aslan Pharmaceuticals are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Aslan Pharmaceuticals i.e., Aslan Pharmaceuticals and Agios Pharm go up and down completely randomly.

Pair Corralation between Aslan Pharmaceuticals and Agios Pharm

Given the investment horizon of 90 days Aslan Pharmaceuticals is expected to under-perform the Agios Pharm. In addition to that, Aslan Pharmaceuticals is 3.92 times more volatile than Agios Pharm. It trades about -0.03 of its total potential returns per unit of risk. Agios Pharm is currently generating about 0.06 per unit of volatility. If you would invest  2,869  in Agios Pharm on August 29, 2024 and sell it today you would earn a total of  3,041  from holding Agios Pharm or generate 106.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy81.62%
ValuesDaily Returns

Aslan Pharmaceuticals  vs.  Agios Pharm

 Performance 
       Timeline  
Aslan Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aslan Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Aslan Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Agios Pharm 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.

Aslan Pharmaceuticals and Agios Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aslan Pharmaceuticals and Agios Pharm

The main advantage of trading using opposite Aslan Pharmaceuticals and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aslan Pharmaceuticals position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.
The idea behind Aslan Pharmaceuticals and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes